Editorial
Published on 22 Dec 2022
Editorial: Reviews in hematologic malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1105523
- 1,526 views
Type at least 3 characters
1,748 articles
Articles
Case Report
Published on 21 Dec 2022
A case report of synchronous triple primary malignancies: Diffuse large B-cell lymphoma, rectal adenocarcinoma and hepatocellular carcinoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1046878
- 1,868 views
- 1 citation
Original Research
Published on 20 Dec 2022
The adverse impact of a gain in chromosome 1q on the prognosis of multiple myeloma treated with bortezomib-based regimens: A retrospective single-center study in China
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1084683
- 3,722 views
- 3 citations
Review
Published on 20 Dec 2022
Classification and challenges in the histopathological diagnosis of peripheral T-cell lymphomas, emphasis on the WHO-HAEM5 updates
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1099265
- 5,092 views
- 6 citations
Original Research
Published on 20 Dec 2022
The role of lymphoid tissue SPARC in the pathogenesis and response to treatment of multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1009993
- 1,871 views
- 1 citation
Original Research
Published on 20 Dec 2022
Systematic discrimination of the repetitive genome in proximity of ferroptosis genes and a novel prognostic signature correlating with the oncogenic lncRNA CRNDE in multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1026153
- 2,759 views
- 4 citations
Review
Published on 19 Dec 2022
Cancer-associated fibroblasts in acute leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1022979
- 3,275 views
- 3 citations
Correction
Published on 15 Dec 2022
Corrigendum: Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1116757
- 1,027 views
Original Research
Published on 15 Dec 2022
Increased PD-1+Foxp3+ γδ T cells associate with poor overall survival for patients with acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1007565
- 2,332 views
- 7 citations
Case Report
Published on 15 Dec 2022
Torque teno mini virus driven childhood acute promyelocytic leukemia: The third case report and sequence analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1074913
- 1,995 views
- 10 citations
Editorial
Published on 15 Dec 2022
Editorial: Risk-stratification in myelodysplastic syndromes
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1095847
- 1,084 views
Review
Published on 15 Dec 2022
Diagnosis and management of AL amyloidosis due to B-cell non-Hodgkin lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.915420
- 5,486 views
- 3 citations
Original Research
Published on 13 Dec 2022
Survival trends and prognostic factors for patients with extramedullary plasmacytoma: A population-based study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1052903
- 2,118 views
- 3 citations
Case Report
Published on 12 Dec 2022
Case report: Multicentric Castleman disease as a manifestation of immune reconstitution inflammatory syndrome in Malawi
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.969135
- 1,741 views
- 2 citations
Perspective
Published on 12 Dec 2022
Co-management strategies for acute myeloid leukemia patients in the community setting
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1060912
- 2,936 views
- 1 citation
Original Research
Published on 08 Dec 2022
Enhancing diagnosis of T-cell lymphoma using non-recombined T-cell receptor sequences
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1014132
- 1,664 views
- 1 citation